TeleHab is a digital health platform that sits within VALD Hub, allowing practitioners to prescribe exercise programs, educational material and questionnaires (PROMs) to their patients.
Patients are then guided to complete their assigned programs using the TeleHab patient mobile app. When completing exercise programs, patients can record videos of their assigned exercises that will upload directly into your VALD Hub account, enabling you to monitor adherence and completion rates.
Use the articles linked in this guide to efficiently set up and start using TeleHab in your clinic.
| Set up your software | |
| Create a TeleHab account | Create an organisation and user account in VALD Hub to access TeleHab. |
| Add practitioners to your account | Provide access to your VALD Hub to additional practitioners if necessary. |
| Integrate your PMS / AMS | |
| Cliniko | Integrate your Cliniko software with VALD Hub. |
| Gensolve | Integrate your Gensolve software with VALD Hub. |
| Nookal | Integrate your Nookal software with VALD Hub. |
| PracSuite | Integrate your PracSuite software with VALD Hub. |
| Start using TeleHab | |
| Create and assign an exercise program | Choose from over 7,000 exercises and assign a program to your patients / athletes. |
| Assign an exercise program template | Create and assign different program templates to your patients, saving yourself time if you regularly prescribe the same rehabilitation exercises for certain conditions. |
| Print an exercise program | For patients that don't have access to email, quickly print out their assigned program. |
| Run an online consultation | Conduct a teleconsultation with your patient through VALD Hub. |
| Assign education topics | Provide your patients with further context regarding particular musculoskeletal conditions and interventions. |
| Assign PROMs | Monitor your patients' wellbeing with PROMs - scientifically validated questionnaires that can measure and provide feedback to practitioners regarding treatment efficacy. |
Comments
0 comments
Article is closed for comments.